We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Ultra-Fast Real-Time PCR Platform Could Revolutionize POC Molecular Diagnostics

By LabMedica International staff writers
Posted on 08 Nov 2022

An ultra-fast point-of-care real-time PCR platform for infectious disease diagnostics that is currently under development will be able to deliver results within five minutes at a cost equivalent to antigen tests currently available in the market. More...

Using proprietary technologies, LEX Diagnostics (Melbourn, UK) is developing a platform that could revolutionize point-of-care molecular diagnostics with a step change in speed, sensitivity and cost. The LEX System being developed by LEX Diagnostics aims to deliver true-PCR insights to clinicians at the time they are most valuable, meaning an answer in 5-7 minutes. Amplifying the genetic material over tens of thermal cycles is the bottleneck for conventional PCR systems. LEX’s amplification chambers can be heated or cooled in seconds. The company’s IP enables ultrafast thermocycling without the need for an expensive, unreliable Peltier cooler. This enables a compact, robust reader with a low cost of goods.

RT-PCR is the gold standard for the diagnosis of viral infectious disease. LEX has shown that its platform amplifies viruses with lab-standard sensitivity and selectivity. LEX’s IP protects a cartridge design that can be made from industry standard materials developed by experienced engineers to be within standard process tolerances. The LEX System is compact enough to fit on the bench of the smallest physician’s office lab and simple enough to be used by the newest nurse or the oldest doctor in the practice. It will deliver results quickly enough to support the busiest urgent care yet is affordable enough for the smallest rural pharmacy.

Related Links:
LEX Diagnostics 


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Original illustration showing how exposure-linked mutation patterns may influence tumor immune visibility (Photo courtesy of Máté Manczinger, HUN-REN Szeged BRC)

Cancer Mutation ‘Fingerprints’ to Improve Prediction of Immunotherapy Response

Cancer cells accumulate thousands of genetic mutations, but not all mutations affect tumors in the same way. Some make cancer cells more visible to the immune system, while others allow tumors to evade... Read more

Pathology

view channel
Image: The new methyl-copying PCR method preserves DNA methylation patterns during amplification (Photo courtesy of Syndex Bio)

Novel mcPCR Technology to Transform Testing of Clinical Samples

DNA methylation is an important biological marker used in the diagnosis and monitoring of many diseases, including cancer. These chemical modifications to DNA influence gene activity and can reveal early... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.